Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE FPR Specialty Pharmacy
Slomski's addition and Cleveland Clinic study adds to FPR Specialty Pharmacy's market expansion plans
VICTOR, N.Y., Jan. 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief-custom transdermal creams for pain and inflammation-today announced the appointment of Douglas B. Slomski to the position of Vice President of Sales and Marketing. Effective immediately, Slomski will be responsible for expanding the company's presence in existing markets, as well as opening new markets and launching products. The company also announced today that the Cleveland Clinic study for the treatment of knee pain using Diclofenac Cream 8% or 1% has moved to the next phase, with participant enrollment to begin in the first quarter of 2014.
Slomski brings to FPR Specialty Pharmacy a 25-year background in marketing life-science products and extensive expertise in medical sales management. He most recently served on the management team at ECA Medical Instruments, where he helped with the global unveiling of a line of surgical kitting products and oversaw a five-year branding and implementation program. Known for his solutions-based approach, Slomski is a global expert at growing revenue and market share through end-to-end product management and targeted sales strategies. He is also credited with over 12 patents in medical devices, packaging and sterilization processing equipment.
"FPR Specialty Pharmacy has exciting and aggressive plans to move the company forward in 2014. Doug Slomski is a top talent in the industry and his knowledge will further strengthen our management team and our position to achieve our goals," said Billy Rue, CEO of FPR Specialty Pharmacy.
As part of its expansion efforts, FPR Specialty Pharmacy is engaging in the Cleveland Clinic study to measure the effectiveness of Diclofenac creams in treating knee pain. This research will provide valuable insights for treating pain and inflammation in the knee. "This is a hallmark study for our industry and we greatly value partnering with the Cleveland Clinic on this project," said Rue.
ABOUT FPR SPECIALTY PHARMACY
FPR Specialty Pharmacy is an advanced traditional compounding pharmacy specializing in solutions for relief of pain and inflammation. The company's leading product, Focused Pain Relief, is a custom compounded, prescription-based transdermal cream. FPR Specialty Pharmacy is located in Victor, New York. Learn more at: www.focusedpainrelief.com or follow FPR Specialty Pharmacy on LinkedIn.
©2012 PR Newswire. All Rights Reserved.